Notable News

OKYO Pharma Limited CEO Gary Jacob tells Proactive's Andrew Scott it's time to take the company from development stage and into the clinic

Proactive interview with Gary Jacob

Latest News

28 April 2021

OKYO Pharma Announces Positive Data and Results in an Animal Model using Topically Administered OK-201 to Treat Neuropathic Ocular Pain

29 March 2021

OKYO announces appointment of Dr Rajkumar Patil as Chief Scientific Officer

10 March 2021

OKYO Pharma Limited CEO Gary Jacob tells Proactive's Andrew Scott it's time to take the company from development stage and into the clinic

03 March 2021

ISSUE OF EQUITY - UPDATE

01 March 2021

ISSUE OF EQUITY

23 February 2021

OKYO Pharma has U.S. Patent Issued Covering its Lipid Conjugated Peptide Analogues for treating Ocular Pain and Inflammation

19 January 2021

OKYO announces filing of a patent application covering the use of Chemerin and associated analogues to treat “cytokine storm” associated with COVID-19 and ARDS

07 January 2021

DIRECTORATE CHANGES AND PDMR DEALING

30 November 2020

Interim results for the six months to 30 September 2020

25 September 2020

Upload of Articles of Association to National Storage Mechanism

Page 2 of 6 Previous Next